- ￥3600 - 7500
- 齐源
- 306517
- 国产/进口
- 2025年07月15日
- FC
- 小鼠
- 人、猴
6 年钻石会员
企业认证
相关产品推荐更多 >
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 供应商：
齐源
- 库存：
999
- 靶点：
CD184
- 级别：
CD184 (CXCR4) Antibody
- 目录编号：
CD184 (CXCR4) Antibody
- 克隆性：
单克隆
- 抗原来源：
小鼠
- 保质期：
CD184 (CXCR4) Antibody
- 抗体英文名：
Brilliant Violet 421™ anti-human CD184 (CXCR4) Antibody
- 抗体名：
CD184 (CXCR4) Antibody
- 标记物：
CD184 (CXCR4) Antibody
- 宿主：
小鼠
- 适应物种：
人、猴
- 免疫原：
CD184 (CXCR4) Antibody
- 亚型：
CD184 (CXCR4) Antibody
- 形态：
CD184 (CXCR4) Antibody
- 应用范围：
FC
- 保存条件：
2-8℃
- 浓度：
CD184 (CXCR4) Antibody
- 规格：
25 tests/100 tests
| 规格： | 25 tests | 产品价格： | ￥3600.0 |
|---|---|---|---|
| 规格： | 100 tests | 产品价格： | ￥7500.0 |
Brilliant Violet 421™ anti-human CD184 (CXCR4) Antibody详细如下：
Description ：CD184, also known as fusin or CXCR4, is a 45 kD seven transmembrane G-protein-linked CXCchemokine receptor. CD184 is widely expressed on blood and tissue cells, including B and Tcells, monocytes, macrophages, dendritic cells, granulocytes, megakaryocytes/platelets,lymphoid, myeloid precursor cells, endothelial cells, epithelial cells, astrocytes, and neurons,among other tissue cells. CD184 is the receptor for CXC chemokine SDF-1, mediates bloodcell migration, and is involved in B lymphopoiesis and myelopoiesis, cardiogenesis, bloodvessel formation, and cerebellar development. CXCR4 is also a coreceptor of X4 HIV-1 and analternative receptor for some isolates of HIV-2.
Verified Reactivity ：Human, Cynomolgus, Rhesus
Reported Reactivity ：African Green, Baboon, Chimpanzee, Sooty Mangabey
Antibody Type ：Monoclonal
Host Species ：Mouse
Immunogen ：CP-MAC-infected Sup-T1 cells
Formulation ：Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide and BSA (origin USA).
Preparation ：The antibody was purified by affinity chromatography and conjugated with Brilliant Violet 421™under optimal conditions.
Concentration ：Lot-specific (to obtain lot-specific concentration and expiration, please enter the lot number in ourCertificate of Analysis online tool.)
Storage & Handling ：The antibody solution should be stored undiluted between 2°C and 8°C, and protected fromprolonged exposure to light. Do not freeze.
Application ：FC - Quality tested
Recommended Usage ：Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometricanalysis. For flow cytometric staining, the suggested use of this reagent is 5 µl per million cells in100 µl staining volume or 5 µl per 100 µl of whole blood.
Brilliant Violet 421™ excites at 405 nm and emits at 421 nm. The standard bandpass filter 450/50nm is recommended for detection. Brilliant Violet 421™ is a trademark of Sirigen Group Ltd.
Excitation Laser ：Violet Laser (405 nm)
Description ：CD184, also known as fusin or CXCR4, is a 45 kD seven transmembrane G-protein-linked CXCchemokine receptor. CD184 is widely expressed on blood and tissue cells, including B and Tcells, monocytes, macrophages, dendritic cells, granulocytes, megakaryocytes/platelets,lymphoid, myeloid precursor cells, endothelial cells, epithelial cells, astrocytes, and neurons,among other tissue cells. CD184 is the receptor for CXC chemokine SDF-1, mediates bloodcell migration, and is involved in B lymphopoiesis and myelopoiesis, cardiogenesis, bloodvessel formation, and cerebellar development. CXCR4 is also a coreceptor of X4 HIV-1 and analternative receptor for some isolates of HIV-2.
Verified Reactivity ：Human, Cynomolgus, Rhesus
Reported Reactivity ：African Green, Baboon, Chimpanzee, Sooty Mangabey
Antibody Type ：Monoclonal
Host Species ：Mouse
Immunogen ：CP-MAC-infected Sup-T1 cells
Formulation ：Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide and BSA (origin USA).
Preparation ：The antibody was purified by affinity chromatography and conjugated with Brilliant Violet 421™under optimal conditions.
Concentration ：Lot-specific (to obtain lot-specific concentration and expiration, please enter the lot number in ourCertificate of Analysis online tool.)
Storage & Handling ：The antibody solution should be stored undiluted between 2°C and 8°C, and protected fromprolonged exposure to light. Do not freeze.
Application ：FC - Quality tested
Recommended Usage ：Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometricanalysis. For flow cytometric staining, the suggested use of this reagent is 5 µl per million cells in100 µl staining volume or 5 µl per 100 µl of whole blood.
Brilliant Violet 421™ excites at 405 nm and emits at 421 nm. The standard bandpass filter 450/50nm is recommended for detection. Brilliant Violet 421™ is a trademark of Sirigen Group Ltd.
Excitation Laser ：Violet Laser (405 nm)
风险提示：丁香通仅作为第三方平台，为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全，合理判断，谨慎选购商品，商家和用户对交易行为负责。对于医疗器械类产品，请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验该产品被引用文献
Application References(PubMed link indicatesBioLegend citation)：
1. McKnight A, et al. 1997. J. Virol. 71:1692.
2. Endres MJ, et al. 1996. Cell 87:745. (Immunogen, IF)
3. Volin MV, et al. 1998. Biochem. Biophys. Res. Commun. 242:46. (ICC)
4. Berndt C, et al. 1998. P. Natl. Acad. Sci. USA 95:12556. (Block)
5. Ullrich CK, et al. 2000. Blood 96:1438. (Block)
6. Murga M, et al. 2005. Blood 105:1992. (IF)
7. Thompson BD. 2007. J. Biol. Chem. 282:9547. (FC) PubMed
8. Isnardi I, et al. 2010. Blood 115:5026. PubMed
9. Yoshino N, et al. 2000. Exp. Anim. (Tokyo) 49:97. (FC)
10. Fischer T, et al. 2008. PLoS One 3:e4069.
11. Schmid BC, et al. 2004. Breast Cancer Res. Treat. 84:247. (IHC)
Product Citations：
1. Hinks TSC, et al. 2019. Cell Rep. 28:3249. PubMed
2. Saxena S, et al. 2016. Stem Cell Reports. 6: 692-703. PubMed
3. Terenzi DC, et al. 2021. STAR Protoc. 2:100311. PubMed
4. Tabler C, et al. 2014. J Virol. 88:4976. PubMed
5. Mair B et al. 2019. Cell reports. 27(2):599-615 . PubMed
6. Smulski C, et al. 2017. Cell Rep. 18(9):2189-2202. PubMed
7. Xu J, et al. 2017. Clin Cancer Res. 23:4482. PubMed
8. Garcia F, et al. 2020. Sci Rep. 10:14262. PubMed
9. Demberg T, et al. 2014. Clin Immunol. 153:264. PubMed
10. Gage BK, et al. 2020. Cell Stem Cell. 27(2):254-269.e9. PubMed
1. McKnight A, et al. 1997. J. Virol. 71:1692.
2. Endres MJ, et al. 1996. Cell 87:745. (Immunogen, IF)
3. Volin MV, et al. 1998. Biochem. Biophys. Res. Commun. 242:46. (ICC)
4. Berndt C, et al. 1998. P. Natl. Acad. Sci. USA 95:12556. (Block)
5. Ullrich CK, et al. 2000. Blood 96:1438. (Block)
6. Murga M, et al. 2005. Blood 105:1992. (IF)
7. Thompson BD. 2007. J. Biol. Chem. 282:9547. (FC) PubMed
8. Isnardi I, et al. 2010. Blood 115:5026. PubMed
9. Yoshino N, et al. 2000. Exp. Anim. (Tokyo) 49:97. (FC)
10. Fischer T, et al. 2008. PLoS One 3:e4069.
11. Schmid BC, et al. 2004. Breast Cancer Res. Treat. 84:247. (IHC)
Product Citations：
1. Hinks TSC, et al. 2019. Cell Rep. 28:3249. PubMed
2. Saxena S, et al. 2016. Stem Cell Reports. 6: 692-703. PubMed
3. Terenzi DC, et al. 2021. STAR Protoc. 2:100311. PubMed
4. Tabler C, et al. 2014. J Virol. 88:4976. PubMed
5. Mair B et al. 2019. Cell reports. 27(2):599-615 . PubMed
6. Smulski C, et al. 2017. Cell Rep. 18(9):2189-2202. PubMed
7. Xu J, et al. 2017. Clin Cancer Res. 23:4482. PubMed
8. Garcia F, et al. 2020. Sci Rep. 10:14262. PubMed
9. Demberg T, et al. 2014. Clin Immunol. 153:264. PubMed
10. Gage BK, et al. 2020. Cell Stem Cell. 27(2):254-269.e9. PubMed
文献支持
Brilliant Violet 421™ 抗人 CD184 (CXCR4) 抗体
￥3600 - 7500
